News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Apitope Progresses Graves' Disease Treatment


6/19/2014 6:28:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DIEPENBEEK, Belgium, June 19, 2014 /PRNewswire/ --

Initiates Preclinical Development of Peptide Therapy

Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.

Help employers find you! Check out all the jobs and post your resume.

Read at Yahoo Finance

comments powered by Disqus
Apitope
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES